Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eratrectinib (VC004) in advanced solid tumors
NCT04614740Phase 2Unknown
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Nov 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eratrectinib in solid tumor, sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Status: unknown.
02
Drugs
eratrectinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04614740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04614740.